SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (1363)5/14/1998 5:17:00 PM
From: celeryroot.com  Read Replies (2) of 2173
 
worded a little stronger else where, very costly for J&J

" Panelists questioned whether Ergoset worked the way the company claimed, and said Ergo Science had not adequately
shown that the drug would be safe and effective for long-term u

"When one looks at the data, one has to take into account there is an effect," said Panel Chairman Robert Sherwin of
Yale University. "It's statistically significant, but modest, and not durable."

"It is a tease in the positive direction," he added."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News